← All Sponsors
SPONSOR

Seoul National University Hospital

Total Trials
21
Recruiting
21
Phases
Phase 4, Phase 3

Seoul National University Hospital is a clinical research sponsor with 21 registered studies on ClinicalTrials.gov, of which 21 are actively recruiting participants. Research covers conditions including Primary Aldosteronism, Secondary Hypertension, Aldosterone-Producing Adenoma, Idiopathic Hyperaldosteronism.

The trial portfolio spans Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Seoul National University Hospital

How many clinical trials has Seoul National University Hospital sponsored?
ClinicalMetric currently tracks 21 clinical trials sponsored by Seoul National University Hospital, of which 21 are actively recruiting participants. These trials cover conditions including Primary Aldosteronism, Secondary Hypertension, Aldosterone-Producing Adenoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Seoul National University Hospital research focus on?
Seoul National University Hospital clinical trials span Primary Aldosteronism, Secondary Hypertension, Aldosterone-Producing Adenoma, Idiopathic Hyperaldosteronism, Adrenalectomy, and additional conditions. The research pipeline includes Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Seoul National University Hospital clinical trial?
To participate in a Seoul National University Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Seoul National University Hospital trials with current recruitment status updated daily.

Clinical Trials by Seoul National University Hospital

NCT07027254
Recruiting

PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism

Primary Aldosteronism
NCT05996159
Recruiting

Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation

Paroxysmal Atrial Fibrillation
NCT05763277
Recruiting

Ate-Bev Early Response Prediction Model in Advanced HCC

Hepatocellular Carcinoma
NCT06712108
Recruiting

Double Unit Cord Blood Transplant in Hematologic Malignancies.

Adult Double Unit Cord Blood Transplant
NCT06216769
Recruiting

Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation

Atrial Fibrillation
NCT06979219
Recruiting

Streamlining Radioembolization for Small HCC

Hepatocellular Carcinoma (HCC)
NCT06552299
Recruiting

Evaluating Length and Depth Estimation Accuracy of Laypersons and Health-Care Providers

Cardiopulmonary Resuscitation
NCT06928818
Recruiting

Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea

Cancer of Breast
NCT06925282
Recruiting

Determinants of Rescue Ventilation Requirement in Airway Surgery Under General Anesthesia With THRIVE

Subglottic Stenosis (SGS)
NCT04622540
Recruiting

EBD RCT Trial in Living Donor Liver Transplantation

Liver Transplantation
NCT04643106
Recruiting

Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function

Benign Ovarian Cyst
NCT07675850 Phase 4
Recruiting

Efficacy and Safety of Eleveld PK/PD Model-based Dosing During General Anesthesia

Remimazolam
NCT07476651
Recruiting

Scout Dose of Resin Microspheres

Radioembolization
NCT05950958
Recruiting

Prevention of Delirium in ICU Using Multimodal Interventions

Intensive Care Unit Delirium
NCT05845489 Phase 4
Recruiting

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)

Coronary Artery Disease
NCT07638241
Recruiting

Agentic AI Personalized Dietary Management Study

Dietary Behavior; Metabolic Health; Obesity; Lifestyle Modification; Metabolic Syndrome Risk
NCT05534087 Phase 3
Recruiting

Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)

Colon Cancer
NCT06454149
Recruiting

Cohort Study for Gastric MALT Lymphoma

Gastric MALT Lymphoma
NCT06710405 Phase 4
Recruiting

The Effect of Intraoperative Intravenous Lidocaine Infusion on Postoperative Pain and Recovery in Children (< 7 Years Old) Undergoing Thoracoscopic Surgery

Pain Management After Surgery
NCT06479122 Phase 4
Recruiting

Efficacy of Acetaminophen Alone Versus Combination of Acetaminophen/Ibuprofen After Cesarean Section

Cesarean Section
NCT02936232
Recruiting

Severe Sepsis and Septic Shock Registry

Sepsis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology